Guobang Pharma Ltd. (SHA:605507)
China · Delayed Price · Currency is CNY 25.82
+0.38 (1.49%)
Apr 8, 2026, 3:00 PM CST
Guobang Pharma Market Cap
Guobang Pharma has a market cap or net worth of 14.28 billion as of April 8, 2026. Its market cap has increased by 34.90% in one year.
Market Cap
14.28B
Enterprise Value
12.57B
Revenue
6.01B
Ranking
n/a
PE Ratio
17.45
Stock Price
25.82
Market Cap Chart
Since August 2, 2021, Guobang Pharma's market cap has decreased from 26.21B to 14.28B, a decrease of -45.52%. That is a compound annual growth rate of -12.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 7, 2026 | 14.07B | 2.58% |
| Dec 31, 2025 | 13.71B | 19.12% |
| Dec 31, 2024 | 11.51B | 17.32% |
| Dec 29, 2023 | 9.81B | -33.66% |
| Dec 30, 2022 | 14.79B | -8.19% |
| Dec 31, 2021 | 16.11B | -38.53% |
| Aug 2, 2021 | 26.21B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanjing King-Friend Biochemical Pharmaceutical | 15.62B |
| Shenzhen Kangtai Biological Products | 15.42B |
| Shenzhen Hepalink Pharmaceutical Group | 15.13B |
| Zhejiang Jiuzhou Pharmaceutical | 15.03B |
| Zhejiang Medicine | 14.94B |
| Beijing Aosaikang Pharmaceutical | 14.82B |
| Shanghai Haoyuan Chemexpress | 14.79B |
| Shanghai Shyndec Pharmaceutical | 14.14B |